How price control raises your healthcare costs  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏
 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏





View in browser
<[link removed]>
||UNSUBSCRIBE
<[link removed]->

<[link removed]->





<[link removed]
AFP-NTL_NSLT-HC_240815_na_PO-NSLT-HC60dActives&utm_content=text1>





Hello John,

‌

This week marks the two-year anniversary of the misnamed Inflation Reduction
Act (IRA).

‌

Not only has this law ironically served to drive up inflation, but it also has
had a big impact on the pharmaceutical industry.Just not in the way that the
Biden-Harris Administration would have you believe.

‌

The IRA’s drug price-fixing scheme is leading to significant reductions in
research and development (R&D) investments by major pharmaceutical companies.
It’s also driving up the cost of prescription drug coverage for seniors.

‌

While the President and Vice President tout potential savings from price
controls, the reality is grim: future treatments are being shelved.
Pharmaceutical companies, under pressure to cut prices, are scaling back
investments in new drugs.

‌

Drug development is costly and risky, and with reduced R&D budgets, fewer
innovations will emerge. This means fewer treatments for diseases like
Alzheimer's, cancer, and rare genetic disorders, which desperately need ongoing
research.

‌

The IRA is also making Medicare Part D prescription drug coverage more
expensive.According to the Wall Street Journal
<[link removed]>
, “insurers report that many Part D plan premiums will rise far more than 6%
next year,” when the IRA’s “redesign” of the program takes effect.”

‌

Medicare's actuaries estimate
<[link removed]>
the average cost of providing drug coverage will rise from $64.20 to $179.45 a
month -- a 179% increase.That’s real money coming out of your wallet.

‌

While trying to make prescription drugs more affordable is a worthy goal, the
Biden-Harris Administration’s price-fixing approach is deeply flawed. Price
controls stifle innovation and hinder the development of new, life-saving
treatments.

‌

Americans can’t afford government price controls. You should be in charge of
your medicine cabinet, not politicians. A Personal Option
<[link removed]
AFP-NTL_NSLT-HC_240815_na_PO-NSLT-HC60dActives&utm_content=text1> would bring
you the medicines you need at prices you can afford.

‌

Learn more about how the Personal Option, not price controls, is the solution
to high drug prices.


Learn about the Personal Option
<[link removed]
AFP-NTL_NSLT-HC_240815_na_PO-NSLT-HC60dActives&utm_content=text1>





Best Regards,

‌

Best,

‌

Dean Clancy

Americans for Prosperity 

PersonalOption.com
<[link removed]
AFP-NTL_NSLT-HC_240815_na_PO-NSLT-HC60dActives&utm_content=text1>






Americans for Prosperity

4201 Wilson Blvd, Suite 1000

Arlington, VA 22203



This email was sent to:

[email protected]




UNSUBSCRIBE
<[link removed]->
•PRIVACY POLICY
<[link removed]
AFP-NTL_NSLT-HC_240815_na_PO-NSLT-HC60dActives&utm_content=privacy> • VIEW
ONLINE
<[link removed]>


<[link removed]
AFP-NTL_NSLT-HC_240815_na_PO-NSLT-HC60dActives&utm_content=footer>